显微镜下手术机器人企业深度医疗完成A轮融资
机器人圈·2026-02-05 09:27

Core Viewpoint - Guangzhou Deep Medical Instrument Technology Co., Ltd. has completed its Series A financing, indicating strong interest from medical investment funds in the field of microscope surgical robots and recognition of the company's unique technology and execution capabilities [1][3]. Group 1: Company Overview - Deep Medical is a founding member of the Microsurgery Branch of the China Medical Device Industry Association, focusing on intelligent devices for all aspects of microscope surgery [3][17]. - The flagship product, FUNZAR microscope surgical robot, has been recognized as a significant advancement in microsurgery for two consecutive years (2024/2025) and was ranked first among the top five advancements in 2025 [3][17]. Group 2: Technological Innovation - FUNZAR is the world's first modular universal microscope surgical robot system, aiming to redefine the standards of microscope surgery with its innovative design [8][9]. - The system features hand-eye integration with a magnification capability of 10-100 times, allowing surgeons to operate with precision [8]. - FUNZAR employs a modular design with multiple robotic arms, enabling autonomous operations without the need for assistant surgeons [9][10]. Group 3: Clinical Progress - Since its official operation in April 2024, Deep Medical has rapidly progressed through product development, animal testing, and clinical trials, achieving the first clinical enrollment in December 2024 [12]. - Clinical trials for FUNZAR are currently underway in top hospitals across Beijing, Shanghai, Changsha, and Guangzhou, demonstrating its technical advantages and stability [12]. Group 4: Investment and Support - The company has received continuous support from investors like Wanfu Chuanggu and Kangjun Capital, who recognize the strategic value of universal microscope surgical robots [13][14]. - Kangjun Capital emphasizes the innovative technology and execution capabilities of the team, highlighting the potential for FUNZAR to address clinical challenges in microsurgery [14][16].